부산대학교 도서관

Schoenfeld, Jonathan D ; Giobbie-Hurder, Anita; Ranasinghe, Srinika; Kao, Katrina Z; Lako, Ana; Tsuji, Junko; Liu, Yang; Brennick, Ryan C; Gentzler, Ryan D; Lee, Carrie; Hubbard, Joleen; Arnold, Susanne M; Abbruzzese, James L; Jabbour, Salma K; Uboha, Nataliya V; Stephans, Kevin L; Johnson, Jennifer M; Park, Haeseong; Villaruz, Liza C; Sharon, Elad; Streicher, Howard; Ahmed, Mansoor M; Lyon, Hayley; Cibuskis, Carrie; Lennon, Niall; Jhaveri, Aashna; Yang, Lin; Altreuter, Jennifer; Gunasti, Lauren; Weirather, Jason L; Mak, Raymond H; Awad, Mark M; Rodig, Scott J; Chen, Helen X; Wu, Catherine J; Monjazeb, Arta M; Hodi, F Stephen

In The Lancet Oncology February 2022 23(2):279-291

Monjazeb, Arta M; Giobbie-Hurder, Anita; Lako, Ana; Thrash, Emily M; Brennick, Ryan C; Kao, Katrina Z; Manuszak, Claire; Gentzler, Ryan D; Tesfaye, Anteneh; Jabbour, Salma K; Alese, Olatunji B; Rahma, Osama E; Cleary, James M; Sharon, Elad; Mamon, Harvey J; Cho, May; Streicher, Howard; Chen, Helen X; Ahmed, Mansoor M; Mariño-Enríquez, Adrian; Kim-Schulze, Seunghee; Gnjatic, Sacha; Maverakis, Emanual; Marusina, Alina I; Merleev, Alexander A; Severgnini, Mariano; Pfaff, Kathleen L; Lindsay, James; Weirather, Jason L; Ranasinghe, Srinika; Spektor, Alexander; Rodig, Scott J; Hodi, F Stephen; Schoenfeld, Jonathan D

Clinical Cancer Research. 27(9)

Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Giobbie-Hurder A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Division of Biostatistics, Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Adu-Berchie K; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.; Ranasinghe S; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lako A; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Severgnini M; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Thrash EM; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Weirather JL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Baginska J; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Manos MP; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Doherty EJ; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.; Attivare Therapeutics Inc., Natick, Massachusetts.; Stafford A; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.; Daley H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ritz J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cell Manipulation Core Facility, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ott PA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Yoon CH; Department of Surgery, Brigham and Women's Hospital, Boston, Massachusetts.; Dranoff G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mooney DJ; Wyss Institute for Biologically Inspired Engineering at Harvard University, Boston, Massachusetts.; Harvard Paulson School of Engineering and Applied Sciences, Cambridge, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Sussman TA; Taussig Cancer Institute, Cleveland Clinic, Cleveland, Ohio, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Giobbie-Hurder A; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Dryg ID; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Manos M; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Melanoma Disease Center, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Weirather JL; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; LeBoeuf NR; Department of Dermatology, Center for Cutaneous Oncology, Brigham and Women's Hospital, Boston, Massachusetts, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.; Connors JM; Division of Hematology, Brigham and Women's Hospital, Boston, Massachusetts, USA jconnors@bwh.harvard.edu.

Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE

Schoenfeld JD; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.; Azad NS; Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, Maryland.; Gross J; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Leidos Biomedical Research Inc., Frederick, Maryland.; Overman MJ; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Kao K; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Jackson L; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Brunnquell D; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Bu X; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Coppola C; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Guan P; Cancer Diagnosis Program, National Cancer Institute, Bethesda, Maryland.; Lee J; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Sims D; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Fuchs R; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Weirather JL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gunasti L; Department of Radiation Oncology, Brigham and Women's Hospital and Dana-Farber Cancer Institute, Boston, Massachusetts.; Ranasinghe S; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Hamilton SR; City of Hope National Medical Center, Duarte, California.; Wang V; Dana-Farber Cancer Institute-ECOG-ACRIN Biostatistics Center, Boston, Massachusetts.; O'Dwyer PJ; Abramson Cancer Center, University of Pennsylvania, Philadelphia, Pennsylvania.; Wu CJ; Center for Hematologic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Patton DR; Center for Biomedical Informatics & Information Technology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.; Harris L; Cancer Diagnosis Program, National Cancer Institute, Bethesda, Maryland.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Paczkowska J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Tang M; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Astra Zeneca, Waltham, MA, USA.; Wright KT; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK, USA.; Song L; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biomedical Data Science, Dartmouth College, Hanover, NH, USA.; Luu K; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; PathAI, Boston, MA, USA.; Shanmugam V; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Welsh EL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Weirather JL; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Besson N; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Olszewski H; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Porter BA; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Pfaff KL; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Redd RA; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Cader FZ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; AstraZeneca, City House, Cambridge, UK.; Mandato E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ouyang J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Mechanisms of Cancer Resistance Thematic Center, Bristol Myers Squibb, Cambridge, MA, USA.; Calabretta E; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Bai G; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Biomolecular Engineering, University of California, Santa Cruz, Santa Cruz, CA, USA.; Lawton LN; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Armand P; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Liu XS; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard T.H. Chan School of Public Health, Boston, MA, USA.; GV20 Therapeutics, LLC, Cambridge, MA, USA.; Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA. Margaret_Shipp@dfci.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Chen J; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Tarantino G; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Severgnini M; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Baginska J; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Giobbie-Hurder A; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Weirather JL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Department of Data Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.; Manos M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Russell JD; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Huang AY; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Brennick R; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Nazzaro M; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Hathaway E; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Holovatska M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Manuszak C; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Ranasinghe S; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Liu D; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of MIT and Harvard, Cambridge, MA, USA.; Harvard Medical School, Boston, MA, USA.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; Harvard Medical School, Boston, MA, USA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.

Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE

Ricciuti B; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lamberti G; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Puchala SR; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Mahadevan NR; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Lin JR; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA.; Alessi JV; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Chowdhury A; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Li YY; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Wang X; Harvard School of Public Health, Boston, MA.; Spurr L; Cancer Program, Broad Institute of MIT and Harvard, Cambridge, MA.; Pecci F; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Di Federico A; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Venkatraman D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Barrichello AP; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Gandhi M; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Vaz VR; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Pangilinan AJ; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Haradon D; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Lee E; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Gupta H; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Pfaff KL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA.; Welsh EL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA.; Nishino M; Department of Radiology, Brigham and Women's Hospital, Boston, MA.; Cherniack AD; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA.; Johnson BE; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.; Weirather JL; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA.; Dryg ID; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, MA.; Sholl LM; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Sorger P; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA.; Santagata S; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Medical School, Boston, MA.; Ludwig Center at Harvard, Harvard Medical School, Boston, MA.; Umeton R; Department of Informatics and Analytics, Dana-Farber Cancer Institute, Boston, MA.; Awad MM; Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, MA.

Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-7755 (Electronic) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE

Haddox CL; Sarcoma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nathenson MJ; Sarcoma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Mazzola E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lin JR; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.; Baginska J; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nau A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Weirather JL; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Choy E; Division of Hematology Oncology, Massachusetts General Cancer Center, Boston, Massachusetts.; Marino-Enriquez A; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Morgan JA; Sarcoma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Cote GM; Division of Hematology Oncology, Massachusetts General Cancer Center, Boston, Massachusetts.; Merriam P; Sarcoma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wagner AJ; Sarcoma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Sorger PK; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.; Santagata S; Department of Systems Biology, Harvard Medical School, Boston, Massachusetts.; Laboratory of Systems Pharmacology, Harvard Medical School, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; George S; Sarcoma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Zhao W; Kepecs B; Mahadevan NR; Segerstolpe A; Weirather JL; Besson NR; Giotti B; Soong BY; Li C; Vigneau S; Slyper M; Wakiro I; Jane-Valbuena J; Ashenberg O; Rotem A; Bueno R; Rozenblatt-Rosen O; Pfaff K; Rodig S; Hata AN; Regev A; Johnson BE; Tsankov AM

Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE

Shaban M; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.; Cancer Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Bai Y; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Qiu H; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Mao S; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Yeung J; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Yeo YY; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.; Shanmugam V; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Broad Institute of Harvard and MIT, Cambridge, MA, USA.; Chen H; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Zhu B; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Weirather JL; Cancer Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA.; Center for Immuno-oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Nolan GP; Department of Pathology, Stanford University School of Medicine, Stanford, CA, USA.; Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA.; Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.; Jiang S; Broad Institute of Harvard and MIT, Cambridge, MA, USA. sjiang3@bidmc.harvard.edu.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. sjiang3@bidmc.harvard.edu.; Department of Pathology, Dana Farber Cancer Institute, Boston, MA, USA. sjiang3@bidmc.harvard.edu.; Mahmood F; Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, USA. faisalmahmood@bwh.harvard.edu.; Department of Pathology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA. faisalmahmood@bwh.harvard.edu.; Cancer Data Science Program, Dana-Farber Cancer Institute, Boston, MA, USA. faisalmahmood@bwh.harvard.edu.; Broad Institute of Harvard and MIT, Cambridge, MA, USA. faisalmahmood@bwh.harvard.edu.

Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101528555 Publication Model: Electronic Cited Medium: Internet ISSN: 2041-1723 (Electronic) Linking ISSN: 20411723 NLM ISO Abbreviation: Nat Commun Subsets: MEDLINE

Tabasum S; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Thapa D; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Giobbie-Hurder A; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Division of Biostatistics, Department of Data Sciences, Dana-Farber Cancer Institute, Boston, Massachusetts.; Weirather JL; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Campisi M; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Schol PJ; Department of Medical Oncology, Oncode Institute, Leiden University Medical Center, Leiden, the Netherlands.; Li X; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Li J; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Yoon CH; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Manos MP; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Barbie DA; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Melanoma Disease Center, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute and Harvard Medical School, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Monjazeb, Arta M; Monjazeb, Arta M; Giobbie-Hurder, Anita; Lako, Ana; Thrash, Emily M; Brennick, Ryan C; Kao, Katrina Z; Manuszak, Claire; Gentzler, Ryan D; Tesfaye, Anteneh; Jabbour, Salma K; Alese, Olatunji B; Rahma, Osama E; Cleary, James M; Sharon, Elad; Mamon, Harvey J; Cho, May; Streicher, Howard; Chen, Helen X; Ahmed, Mansoor M; Mariño-Enríquez, Adrian; Kim-Schulze, Seunghee; Gnjatic, Sacha; Maverakis, Emanual; Marusina, Alina I; Merleev, Alexander A; Severgnini, Mariano; Pfaff, Kathleen L; Lindsay, James; Weirather, Jason L; Ranasinghe, Srinika; Spektor, Alexander; Rodig, Scott J; Hodi, Stephen F; Schoenfeld, Jonathan D

Clinical cancer research : an official journal of the American Association for Cancer Research; vol 27, iss 9, 2470-2480; 1078-0432

Wright KT; Department of Pathology, Brigham and Women's Hospital, Boston, MA.; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, OK.; Weirather JL; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA.; Jiang S; Department of Microbiology and Immunology, Stanford University, Palo Alto, CA.; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Boston, MA.; Kao KZ; Center for Immuno-oncology, Dana-Farber Cancer Institute, Boston, MA.; Sigal Y; Ionpath Inc, Palo Alto, CA.; Giobbie-Hurder A; Department of Data Science, Dana-Farber Cancer Institute, Boston, MA.; Shipp MA; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.; Rodig SJ; Department of Pathology, Brigham and Women's Hospital, Boston, MA.

Publisher: American Society of Hematology Country of Publication: United States NLM ID: 101698425 Publication Model: Print Cited Medium: Internet ISSN: 2473-9537 (Electronic) Linking ISSN: 24739529 NLM ISO Abbreviation: Blood Adv Subsets: MEDLINE

de la Garza, Gabriel; Schleiffarth, Jack Robert; Dunnwald, Martine; Mankad, Anuj; Weirather, Jason L; Bonde, Gregory; Butcher, Stephen; Mansour, Tamer A; Kousa, Youssef A; Fukazawa, Cindy F; Houston, Douglas W; Manak, J Robert; Schutte, Brian C; Wagner, Daniel S; Cornell, Robert A

Journal of Investigative Dermatology. Jan2013, Vol. 133 Issue 1, p68-77. 10p.

Ademuyiwa FO; Washington University School of Medicine, St Louis, MO, 63110, USA. bisiademuyiwa@wustl.edu.; Gao F; Washington University School of Medicine, St Louis, MO, 63110, USA.; Street CR; Washington University School of Medicine, St Louis, MO, 63110, USA.; Chen I; Washington University School of Medicine, St Louis, MO, 63110, USA.; Northfelt DW; Mayo Clinic, Phoenix, AZ, 85054, USA.; Wesolowski R; Ohio State University Comprehensive Cancer Center, Columbus, OH, 43210, USA.; Arora M; UC Davis Comprehensive Cancer Center, Sacramento, CA, 95817, USA.; Brufsky A; University of Pittsburgh School of Medicine, Pittsburgh, PA, 15213, USA.; Dees EC; University of North Carolina School of Medicine, Chapel Hill, NC, 27514, USA.; Santa-Maria CA; The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, 21287, USA.; Connolly RM; University College Cork, Cork, Ireland.; Force J; Duke University School of Medicine, Durham, NC, 27710, USA.; Moreno-Aspitia A; Mayo Clinic, Jacksonville, FL, 32224, USA.; Herndon JM; Washington University School of Medicine, St Louis, MO, 63110, USA.; Carmody M; Washington University School of Medicine, St Louis, MO, 63110, USA.; Davies SR; Washington University School of Medicine, St Louis, MO, 63110, USA.; Larson S; Washington University School of Medicine, St Louis, MO, 63110, USA.; Pfaff KL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Jones SM; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Weirather JL; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Giobbie-Hurder A; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Rodig SJ; Cancer Immune Monitoring and Analysis Center, Dana-Farber Cancer Institute, Boston, MA, 02215, USA.; Liu Z; Washington University School of Medicine, St Louis, MO, 63110, USA.; Hagemann IS; Washington University School of Medicine, St Louis, MO, 63110, USA.; Sharon E; National Cancer Institute, Bethesda, MD, 20892, USA.; Gillanders WE; Washington University School of Medicine, St Louis, MO, 63110, USA. gillandersw@wustl.edu.

Publisher: Breast Cancer Research Foundation Country of Publication: United States NLM ID: 101674891 Publication Model: Electronic Cited Medium: Print ISSN: 2374-4677 (Print) Linking ISSN: 23744677 NLM ISO Abbreviation: NPJ Breast Cancer Subsets: PubMed not MEDLINE

Zeng Z; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Gu SS; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Ouardaoui N; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Tymm C; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Yang L; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Wong CJ; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Biomedical Informatics, Harvard Medical School, Boston, Massachusetts.; Li D; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Zhang W; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; School of Life Science and Technology, Tongji University, Shanghai, China.; Wang X; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Weirather JL; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Rodig SJ; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts.; Hodi FS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Brown M; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Liu XS; Department of Data Science, Dana Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 101614637 Publication Model: Print Cited Medium: Internet ISSN: 2326-6074 (Electronic) Linking ISSN: 23266066 NLM ISO Abbreviation: Cancer Immunol Res Subsets: MEDLINE

Jiang S; Department of Pathology, Stanford University, Stanford, CA, USA; Center for Virology and Vaccine Research, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA. Electronic address: sjiang3@bidmc.harvard.edu.; Chan CN; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Rovira-Clavé X; Department of Pathology, Stanford University, Stanford, CA, USA.; Chen H; Department of Pathology, Stanford University, Stanford, CA, USA.; Bai Y; Department of Pathology, Stanford University, Stanford, CA, USA.; Zhu B; Department of Pathology, Stanford University, Stanford, CA, USA.; McCaffrey E; Department of Pathology, Stanford University, Stanford, CA, USA.; Greenwald NF; Department of Pathology, Stanford University, Stanford, CA, USA.; Liu C; Department of Pathology, Stanford University, Stanford, CA, USA.; Barlow GL; Department of Pathology, Stanford University, Stanford, CA, USA.; Weirather JL; Center of Immuno-Oncology, Dana-Faber Cancer Institute, Boston, MA, USA.; Oliveria JP; Department of Pathology, Stanford University, Stanford, CA, USA; Department of Medicine, McMaster University, Hamilton, ON, Canada.; Nakayama T; Department of Pathology, Stanford University, Stanford, CA, USA; Department of Otorhinolaryngology, Jikei University School of Medicine, Tokyo, Japan.; Lee IT; Department of Pathology, Stanford University, Stanford, CA, USA; Division of Allergy, Immunology, and Rheumatology, Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, USA.; Matter MS; Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.; Carlisle AE; Center of Immuno-Oncology, Dana-Faber Cancer Institute, Boston, MA, USA.; Philips D; Department of Pathology, Stanford University, Stanford, CA, USA.; Vazquez G; Department of Pathology, Stanford University, Stanford, CA, USA.; Mukherjee N; Department of Pathology, Stanford University, Stanford, CA, USA.; Busman-Sahay K; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Nekorchuk M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Terry M; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Younger S; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA.; Bosse M; Department of Pathology, Stanford University, Stanford, CA, USA.; Demeter J; Department of Pathology, Stanford University, Stanford, CA, USA.; Rodig SJ; Department of Pathology, Brigham & Women's Hospital, Boston, MA, USA.; Tzankov A; Pathology, Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland.; Goltsev Y; Department of Pathology, Stanford University, Stanford, CA, USA.; McIlwain DR; Department of Pathology, Stanford University, Stanford, CA, USA.; Angelo M; Department of Pathology, Stanford University, Stanford, CA, USA.; Estes JD; Vaccine and Gene Therapy Institute, Oregon Health & Science University, Beaverton, OR, USA; Division of Pathobiology & Immunology, Oregon National Primate Research Center, Oregon Health & Science University, Beaverton, OR, USA. Electronic address: estesja@ohsu.edu.; Nolan GP; Department of Pathology, Stanford University, Stanford, CA, USA. Electronic address: gnolan@stanford.edu.

Publisher: Cell Press Country of Publication: United States NLM ID: 9432918 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1097-4180 (Electronic) Linking ISSN: 10747613 NLM ISO Abbreviation: Immunity Subsets: MEDLINE

Zeng Z; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Fu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Clinical Translational Research Center, Shanghai Pulmonary Hospital, School of Life Science and Technology, Tongji University, Shanghai, China.; Cibulskis C; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Jhaveri A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Gumbs C; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Das B; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Sanchez-Espiridion B; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Janssens S; The Emmes Company, LLC, Rockville, Maryland.; Taing L; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wang J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Clinical Translational Research Center, Shanghai Pulmonary Hospital, School of Life Science and Technology, Tongji University, Shanghai, China.; Lindsay J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Vilimas T; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Zhang J; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Tokheim C; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Sahu A; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Jiang P; Cancer Data Science Lab, Center for Cancer Research, National Cancer Institute, Bethesda, Maryland.; Yan C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.; Duose DY; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Cerami E; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chen L; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Cohen D; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Chen Q; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.; Enos R; The Emmes Company, LLC, Rockville, Maryland.; Huang X; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Lee JJ; Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Liu Y; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Neuberg DS; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Nguyen C; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.; Patterson C; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Sarkar S; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Shukla S; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Translational Immunogenomics Laboratory, Dana-Farber Cancer Institute, Boston, Massachusetts.; Tang M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Biostatistics, Harvard T.H. Chan School of Public Health, Boston, Massachusetts.; Tsuji J; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Uduman M; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wang X; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Weirather JL; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Center for Immuno-Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Yu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Yu J; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts.; Zhang J; Department of Thoracic/Head and Neck Medical Oncology and Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Zhang J; Department of Bioinformatics and Computational Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Meerzaman D; Center for Biomedical Informatics and Information Technology, National Cancer Institute, Bethesda, Maryland.; Thurin M; Cancer Diagnosis Program, Division of Cancer Treatment and Diagnosis, National Cancer Institute, Bethesda, Maryland.; Futreal A; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Karlovich C; Molecular Characterization Laboratory, Frederick National Laboratory for Cancer Research, Frederick, Maryland.; Gabriel SB; Broad Institute of MIT and Harvard, Cambridge, Massachusetts.; Wistuba II; Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Division of Pathology and Laboratory Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas.; Liu XS; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts. cwu@partners.org xsliu@ds.dfci.harvard.edu.; Center for Functional Cancer Epigenetics, Dana-Farber Cancer Institute, Boston, Massachusetts.; Wu CJ; Broad Institute of MIT and Harvard, Cambridge, Massachusetts. cwu@partners.org xsliu@ds.dfci.harvard.edu.; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.; Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE

Monjazeb AM; Giobbie-Hurder A; Lako A; Thrash EM; Brennick RC; Kao KZ; Manuszak C; Gentzler RD; Tesfaye A; Jabbour SK; Alese OB; Rahma OE; Cleary JM; Sharon E; Mamon HJ; Cho M; Streicher H; Chen HX; Ahmed MM; Mariño-Enríquez A; Kim-Schulze S; Gnjatic S; Maverakis E; Marusina AI; Merleev AA; Severgnini M; Pfaff KL; Lindsay J; Weirather JL; Ranasinghe S; Spektor A; Rodig SJ; Hodi FS; Schoenfeld JD

Publisher: American Association for Cancer Research Country of Publication: United States NLM ID: 9502500 Publication Model: Print Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: PubMed not MEDLINE; MEDLINE